Mantle Cell Lymphoma (MCL) Not Yet Recruiting Phase 2 Trials for Lenalidomide (DB00480)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

DBCOND0071979 (Mantle Cell Lymphoma (MCL))Not Yet Recruiting2 IdentifierTitlePurposeDrugs
NCT03863184Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCLTreatment
NCT03891355Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCLTreatment